Posters
(results will display both Free Papers & Poster)
Long-term functional results and patient satisfaction following implantation of the M-flex 630F multifocal intraocular lens
Poster Details
First Author: E.Mrukwa-Kominek POLAND
Co Author(s): P. Stala A. Piotrowska-Gwozdz M. Nowak A. Urgacz-Lechowicz
Abstract Details
Purpose:
To evaluate functional results of different near additions (+3.00 diopters [D] and +4.00 D) of the M-flex 630F refractive multifocal intraocular lens (IOL) and degree of patient satisfaction.
Setting:
Department of Ophthalmology, University Center of Ophthalmology and Oncology, Medical University of Silesia, Katowice, Poland
Methods:
Cataract patients were assigned to receive bilateral +3.00 D IOLs (Group I, 17 patients/ 34 eyes) or +4.00 D IOLs (Group II, 18 patients/ 36 eyes). Follow-up examinations were performed up to 48 months postoperatively. Outcome measures were i) the reduction of spectacle dependence, ii) efficacy, safety of the procedure, iii) patient satisfaction with visual outcomes and iv) improved contrast sensitivity.
Results:
The average uncorrected distance visual acuity in both groups improved significantly (p<0.001) after the surgery. 93% of eyes in Group I and 100% of eyes in Group II gained at least one row of vision (Snellen). There was a significant increase in contrast sensitivity (p<0.001) in both groups for all spatial frequencies (3, 6, 12 and 18 cpd). While a significant increase in the average level of spectacle independence was noted in both groups (p<0.001), the overall increase in satisfaction in visual outcomes was greater in Group II (+4.00 D). No intraoperative complications were reported in either group.
Conclusions:
Implantation of both models of the M-flex 630F multifocal IOL was safe, stable, and effectively reduced dependence on spectacle correction. An improvement in contrast sensitivity for all spatial frequencies was also reported.
Financial Disclosure:
One or more of the authors research is funded, fully or partially, by a competing company, One or more of the authors travel has been funded, fully or partially, by a competing company